biotech · Atopic Dermatitis · Asthma · APGE
Apogee Therapeutics
Apogee Therapeutics trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
WALTHAM, MA, USA HQ
2022 Founded
293 Employees
Public company Type
APGE · NYSE Ticker
Company details
- Status
- Public
- HQ
- WALTHAM, MA, USA
- Founded
- 2022
- Employees
- 293
- Programs
- 8
- Drugs
- 2
- Patents
- 7
Apogee Therapeutics clinical trials
Registry index of 10 ClinicalTrials.gov studies linked to Apogee Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Apogee Therapeutics trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Apogee Therapeutics.
-
APG777, Placebo — Phase 2
Clinical update -
Placebo, APG777 — Phase 2
Clinical update -
sphingosine kinase-2 inhibitor ABC294640 — Phase 1
Clinical update -
ABC294640 — Phase 2
Clinical update -
ABC294640 — Phase 2
Clinical update -
APG777 — Phase 2
Clinical update -
Opaganib — Phase 2
Clinical update -
APG777 — Phase 1
Clinical update